-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on NRX Pharmaceuticals, Maintains $25 Price Target

Benzinga·02/18/2026 16:56:55
Listen to the news
BTIG analyst Thomas Shrader reiterates NRX Pharmaceuticals (NASDAQ:NRXP) with a Buy and maintains $25 price target.